Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News KORU Medical Systems Inc KRMD

Healthcare Medical Devices
KORU Medical Systems, Inc. designs, manufactures, and markets proprietary portable and advanced medical devices primarily for the subcutaneous drug delivery market. The Company is focused on home and specialty infusion solutions. Its focus is primarily concentrated on its mechanical infusion products, the FREEDOM Infusion Systems, which include the FREEDOM60 Syringe Driver, the FreedomEdge... see more

Recent & Breaking News (NDAQ:KRMD)

KORU Medical Systems to Participate in Piper Sandler's 36th Annual Healthcare Conference

Business Wire November 25, 2024

KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance

Business Wire November 13, 2024

KORU Medical Systems to Participate in Upcoming Investor Conferences

Business Wire November 6, 2024

KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge® Infusion System over Manual Syringe Administration for Subcutaneous Oncology Infusion

Business Wire October 31, 2024

KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024

Business Wire October 23, 2024

KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference

Business Wire September 5, 2024

KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance

Business Wire August 7, 2024

KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference

Business Wire July 25, 2024

KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda

Business Wire July 24, 2024

KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024

Business Wire July 17, 2024

KORU Medical Systems Receives Regulatory Clearance for FreedomEdge® Infusion System in Japan

Business Wire July 2, 2024

Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion

Business Wire June 5, 2024

KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic

Business Wire June 4, 2024

KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic

Business Wire May 14, 2024

KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth

Business Wire May 1, 2024

KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024

Business Wire April 17, 2024

KORU Medical Systems Announces Successful Appeal in EU Notified Body Review

Business Wire April 11, 2024

KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference

Business Wire March 18, 2024

KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance

Business Wire March 13, 2024

KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic

Business Wire March 11, 2024